Compare VOC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | DRIO |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 52.8M |
| IPO Year | N/A | 2013 |
| Metric | VOC | DRIO |
|---|---|---|
| Price | $3.11 | $7.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 158.5K | 24.4K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 12.46% | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ $6.00 | $6.10 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $2.60 | $0.41 |
| 52 Week High | $3.84 | $17.74 |
| Indicator | VOC | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 57.17 |
| Support Level | $2.72 | $7.29 |
| Resistance Level | $3.32 | $8.32 |
| Average True Range (ATR) | 0.13 | 0.88 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 47.69 | 80.35 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust. It operates in a single operating and reportable segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.